Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DANSAC-open olanzapine for nausea in advanced cancer without chemotherapy or irradiation
2015-002294-38Phase 4Completed
- Sponsor
- University Hospital Odense
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of olanzapine in nausea ((none)) and Vomiting, sponsored by University Hospital Odense. Primary endpoint: Primary nausea score. Started Jun 2015; status: completed.
02
Drugs
olanzapine
03
Conditions
nausea ((none))Vomiting
Beyond the preview
Go deeper on 2015-002294-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002294-38.